Global and Japan 23-Valent Pneumococcal Polysaccharide Vaccine Market Insights, Forecast to 2027

Global and Japan 23-Valent Pneumococcal Polysaccharide Vaccine Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 23-Valent Pneumococcal Polysaccharide Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Growth Rate by Type
1.2.2 Single Dose Vial
1.2.3 Pre-filled Syringe
1.3 Market by Application
1.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Growth Rate by Application
1.3.2 For Children (2-10)
1.3.3 For Person (10-64)
1.3.4 For The Old (Above or equal to 65)
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Estimates and Forecasts
2.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2016-2027
2.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2016-2027
2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine, Market Size by Region: 2016 VS 2021 VS 2027
2.3 23-Valent Pneumococcal Polysaccharide Vaccine Historical Market Size by Region (2016-2021)
2.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 23-Valent Pneumococcal Polysaccharide Vaccine Market Estimates and Projections by Region (2022-2027)
2.4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Region (2022-2027)
2.4.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Region (2022-2027)
3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Competitor Landscape by Players
3.1 Global Top 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers by Sales
3.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Manufacturer (2016-2021)
3.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers by Revenue
3.2.1 Key 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers Covered: Ranking by Revenue
3.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Manufacturers (2016-2021)
3.2.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers (2016-2021)
3.2.4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by 23-Valent Pneumococcal Polysaccharide Vaccine Revenue in 2020
3.2.6 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Manufacturers
3.4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base Distribution, Product Types
3.4.1 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into 23-Valent Pneumococcal Polysaccharide Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Type (2016-2021)
4.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2016-2021)
4.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2016-2021)
4.1.3 23-Valent Pneumococcal Polysaccharide Vaccine Average Selling Price (ASP) by Type (2016-2021)
4.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Forecast by Type (2022-2027)
4.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Type (2022-2027)
4.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Type (2022-2027)
4.2.3 23-Valent Pneumococcal Polysaccharide Vaccine Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Application (2016-2021)
5.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2016-2021)
5.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2016-2021)
5.1.3 23-Valent Pneumococcal Polysaccharide Vaccine Price by Application (2016-2021)
5.2 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Forecast by Application (2022-2027)
5.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Application (2022-2027)
5.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Application (2022-2027)
5.2.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price Forecast by Application (2022-2027)
6 Japan by Players, Type and Application
6.1 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Market Size YoY Growth 2016-2027
6.1.1 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales YoY Growth 2016-2027
6.1.2 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue YoY Growth 2016-2027
6.1.3 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Market Share in Global Market 2016-2027
6.2 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Players (International and Local Players)
6.2.1 Japan Top 23-Valent Pneumococcal Polysaccharide Vaccine Players by Sales (2016-2021)
6.2.2 Japan Top 23-Valent Pneumococcal Polysaccharide Vaccine Players by Revenue (2016-2021)
6.3 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Historic Market Review by Type (2016-2021)
6.3.1 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2016-2021)
6.3.2 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2016-2021)
6.3.3 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2016-2021)
6.4 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Type (2022-2027)
6.4.2 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Type (2022-2027)
6.4.3 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Price Forecast by Type (2022-2027)
6.5 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Historic Market Review by Application (2016-2021)
6.5.1 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2016-2021)
6.5.2 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2016-2021)
6.5.3 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Price by Application (2016-2021)
6.6 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Application (2022-2027)
6.6.2 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Application (2022-2027)
6.6.3 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Price Forecast by Application (2022-2027)
7 North America
7.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size YoY Growth 2016-2027
7.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
7.2.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2016-2021)
7.2.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Size YoY Growth 2016-2027
8.2 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Region
8.2.1 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2016-2021)
8.2.2 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Size YoY Growth 2016-2027
9.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
9.2.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2016-2021)
9.2.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size YoY Growth 2016-2027
10.2 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
10.2.1 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2016-2021)
10.2.2 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Size YoY Growth 2016-2027
11.2 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
11.2.1 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2016-2021)
11.2.2 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 MSD
12.1.1 MSD Corporation Information
12.1.2 MSD Description and Business Overview
12.1.3 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Products Offered
12.1.5 MSD Recent Development
12.2 Sanofipasteur
12.2.1 Sanofipasteur Corporation Information
12.2.2 Sanofipasteur Description and Business Overview
12.2.3 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Products Offered
12.2.5 Sanofipasteur Recent Development
12.3 CDIBP
12.3.1 CDIBP Corporation Information
12.3.2 CDIBP Description and Business Overview
12.3.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Products Offered
12.3.5 CDIBP Recent Development
12.11 MSD
12.11.1 MSD Corporation Information
12.11.2 MSD Description and Business Overview
12.11.3 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.11.4 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Products Offered
12.11.5 MSD Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 23-Valent Pneumococcal Polysaccharide Vaccine Industry Trends
13.2 23-Valent Pneumococcal Polysaccharide Vaccine Market Drivers
13.3 23-Valent Pneumococcal Polysaccharide Vaccine Market Challenges
13.4 23-Valent Pneumococcal Polysaccharide Vaccine Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 23-Valent Pneumococcal Polysaccharide Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Single Dose Vial
Table 3. Major Manufacturers of Pre-filled Syringe
Table 4. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Growth Rate by Application (2021-2027) & (K Dose)
Table 5. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region (K Dose) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Regions (2016-2021) & (K Dose)
Table 7. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Regions (2016-2021)
Table 8. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Region (2022-2027) & (K Dose)
Table 10. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 11. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Manufacturers (2016-2021) (K Dose)
Table 14. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers by Revenue (US$ Million) in 2020
Table 16. 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers (2016-2021)
Table 18. Global 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global 23-Valent Pneumococcal Polysaccharide Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in 23-Valent Pneumococcal Polysaccharide Vaccine as of 2020)
Table 20. Key Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Price (2016-2021) (US$/Dose)
Table 21. 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Product Type
Table 23. Date of International Manufacturers Enter into 23-Valent Pneumococcal Polysaccharide Vaccine Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2016-2021) (K Dose)
Table 26. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Type (2016-2021)
Table 27. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2016-2021) (US$ Million)
Table 28. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Type (2016-2021)
Table 29. 23-Valent Pneumococcal Polysaccharide Vaccine Average Selling Price (ASP) by Type (2016-2021) & (US$/Dose)
Table 30. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Type (2022-2027) & (K Dose)
Table 31. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Type (2022-2027)
Table 32. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Dose)
Table 35. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2016-2021) (K Dose)
Table 36. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Application (2016-2021)
Table 37. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2016-2021) (US$ Million)
Table 38. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Application (2016-2021)
Table 39. 23-Valent Pneumococcal Polysaccharide Vaccine Average Selling Price (ASP) by Application (2016-2021) & (US$/Dose)
Table 40. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Application (2022-2027) & (K Dose)
Table 41. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Application (2022-2027)
Table 42. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Dose)
Table 45. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) of Key Companies (2016-2021)
Table 46. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Company (2016-2021)
Table 47. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) by Company (2016-2021)
Table 48. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Company (2016-2021)
Table 49. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) by Type (2016-2021)
Table 50. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Type (2016-2021)
Table 51. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Price (US$/Dose) by Type (2016-2021)
Table 53. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) by Type (2022-2027)
Table 54. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Type (2022-2027)
Table 55. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Type (2022-2027)
Table 57. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Price (US$/Dose) by Type (2022-2027)
Table 58. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) by Application (2016-2021)
Table 59. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Application (2016-2021)
Table 60. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Price (US$/Dose) by Application (2016-2021)
Table 62. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) by Application (2022-2027)
Table 63. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Application (2022-2027)
Table 64. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Application (2022-2027)
Table 66. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Price (US$/Dose) by Application (2022-2027)
Table 67. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2016-2021) & (K Dose)
Table 68. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2016-2021)
Table 69. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2016-2021) & (K Dose)
Table 72. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2016-2021)
Table 75. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2016-2021) & (K Dose)
Table 76. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2016-2021)
Table 77. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2016-2021)
Table 79. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2016-2021) & (K Dose)
Table 80. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2016-2021) & (K Dose)
Table 84. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2016-2021)
Table 87. MSD Corporation Information
Table 88. MSD Description and Business Overview
Table 89. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 90. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Product
Table 91. MSD Recent Development
Table 92. Sanofipasteur Corporation Information
Table 93. Sanofipasteur Description and Business Overview
Table 94. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 95. Sanofipasteur Product
Table 96. Sanofipasteur Recent Development
Table 97. CDIBP Corporation Information
Table 98. CDIBP Description and Business Overview
Table 99. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 100. CDIBP Product
Table 101. CDIBP Recent Development
Table 102. 23-Valent Pneumococcal Polysaccharide Vaccine Market Trends
Table 103. 23-Valent Pneumococcal Polysaccharide Vaccine Market Drivers
Table 104. 23-Valent Pneumococcal Polysaccharide Vaccine Market Challenges
Table 105. 23-Valent Pneumococcal Polysaccharide Vaccine Market Restraints
Table 106. 23-Valent Pneumococcal Polysaccharide Vaccine Customers List
Table 107. 23-Valent Pneumococcal Polysaccharide Vaccine Distributors List
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. 23-Valent Pneumococcal Polysaccharide Vaccine Product Picture
Figure 2. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2020 & 2027
Figure 3. Single Dose Vial Product Picture
Figure 4. Pre-filled Syringe Product Picture
Figure 5. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application in 2020 & 2027
Figure 6. For Children (2-10)
Figure 7. For Person (10-64)
Figure 8. For The Old (Above or equal to 65)
Figure 9. 23-Valent Pneumococcal Polysaccharide Vaccine Report Years Considered
Figure 10. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size 2016-2027 (US$ Million)
Figure 12. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2016-2027 (K Dose)
Figure 13. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Market Share by Region: 2021 Versus 2027
Figure 14. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2016-2021)
Figure 15. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region in 2020
Figure 16. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2016-2021)
Figure 17. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region in 2020
Figure 18. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Manufacturer in 2020
Figure 19. The Top 10 and 5 Players Market Share by 23-Valent Pneumococcal Polysaccharide Vaccine Revenue in 2020
Figure 20. 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 21. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2016-2021)
Figure 22. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2020
Figure 23. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2016-2021)
Figure 24. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type in 2020
Figure 25. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2016-2021)
Figure 26. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application in 2020
Figure 27. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2016-2021)
Figure 28. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application in 2020
Figure 29. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate 2016-2027 (K Dose)
Figure 30. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate 2016-2027 (US$ Million)
Figure 31. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Market Share in Global Market 2016-2027
Figure 32. Japan 5 and 10 Largest 23-Valent Pneumococcal Polysaccharide Vaccine Players Market Share by Revenue in 23-Valent Pneumococcal Polysaccharide Vaccine in 2020
Figure 33. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Type (2016-2021)
Figure 34. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate by Type in 2016 & 2020
Figure 35. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Application (2016-2021)
Figure 36. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate by Application in 2016 & 2020
Figure 37. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate 2016-2021 (K Dose)
Figure 38. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 39. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country in 2020
Figure 40. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country in 2020
Figure 41. U.S. 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2016-2021) (K Dose)
Figure 42. U.S. 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Canada 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2016-2021) (K Dose)
Figure 44. Canada 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate 2016-2021 (K Dose)
Figure 46. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 47. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country in 2020
Figure 48. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country in 2020
Figure 49. Germany 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2016-2021) (K Dose)
Figure 50. Germany 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. France 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2016-2021) (K Dose)
Figure 52. France 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. U.K. 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2016-2021) (K Dose)
Figure 54. U.K. 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. Italy 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2016-2021) (K Dose)
Figure 56. Italy 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Russia 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2016-2021) (K Dose)
Figure 58. Russia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate 2016-2021 (K Dose)
Figure 60. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 61. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region in 2020
Figure 62. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region in 2020
Figure 63. China 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2016-2021) (K Dose)
Figure 64. China 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 65. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2016-2021) (K Dose)
Figure 66. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. South Korea 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2016-2021) (K Dose)
Figure 68. South Korea 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. India 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2016-2021) (K Dose)
Figure 70. India 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. Australia 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2016-2021) (K Dose)
Figure 72. Australia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. China Taiwan 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2016-2021) (K Dose)
Figure 74. China Taiwan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Indonesia 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2016-2021) (K Dose)
Figure 76. Indonesia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Thailand 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2016-2021) (K Dose)
Figure 78. Thailand 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Malaysia 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2016-2021) (K Dose)
Figure 80. Malaysia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-20

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Encephalitis Vaccination Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 102

According to our LPI (LP Information) latest study, the global Encephalitis Vaccination market size was valued at US$ 1263.1 million in 2023. With growing demand in downstream market, the Encephalitis Vaccination is forecast to a readjusted size of US$ 1875.5 million by 2030 with a CAGR of 5.8% during review period. The research report highlights the growth potential of the global Encephalitis Vaccination market. Encephalitis Vaccination are expected to show stable growth in the future m......

Global Avian Influenza Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 123

Market Overview of Global Avian Influenza Vaccines market: According to our latest research, the global Avian Influenza Vaccines market looks promising in the next 5 years. As of 2022, the global Avian Influenza Vaccines market was estimated at USD 933.69 million, and it's anticipated to reach USD 1586.45 million in 2028, with a CAGR of 9.24% during the forecast years. Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. ......

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global 23-Valent Pneumococcal Polysaccharide Vaccine market size was valued at US$ 1114.7 million in 2023. With growing demand in downstream market, the 23-Valent Pneumococcal Polysaccharide Vaccine is forecast to a readjusted size of US$ 2265.8 million by 2030 with a CAGR of 10.7% during review period. The research report highlights the growth potential of the global 23-Valent Pneumococcal Polysaccharide Vaccine market. 23-Valent P......

Global Avian Influenza Vaccines Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155

According to our LPI (LP Information) latest study, the global Avian Influenza Vaccines market size was valued at US$ 928.4 million in 2023. With growing demand in downstream market, the Avian Influenza Vaccines is forecast to a readjusted size of US$ 1369 million by 2030 with a CAGR of 5.7% during review period. The research report highlights the growth potential of the global Avian Influenza Vaccines market. Avian Influenza Vaccines are expected to show stable growth in the future mark......

Global Encephalitis Vaccination Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 106

Market Overview of Global Encephalitis Vaccination market: According to our latest research, the global Encephalitis Vaccination market looks promising in the next 5 years. As of 2022, the global Encephalitis Vaccination market was estimated at USD 52963.61 million, and it's anticipated to reach USD 65320.29 million in 2028, with a CAGR of 3.56% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis......

Global Influenza Vaccine Market Research Report 2023

Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 96

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Influenza Vaccine market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Sanofi - CSL - GSK - Viatris - AstraZeneca - Hualan Bio - Changchun Institute of Biological - Sinovac - BCHT - Jiangsu G......

Global Japanese Encephalitis Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 117

Market Overview of Global Japanese Encephalitis Vaccine market: According to our latest research, the global Japanese Encephalitis Vaccine market looks promising in the next 5 years. As of 2022, the global Japanese Encephalitis Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......

Global Influenza Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 14-Dec-2023        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Influenza Vaccine market: According to our latest research, the global Influenza Vaccine market looks promising in the next 5 years. As of 2022, the global Influenza Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by influenza viruses... ......

2023-2031 Report on Global Influenza Vaccine Market by Player, Region, Type, Application and Sales Channel

Published: 11-Dec-2023        Price: US 2500 Onwards        Pages: 107

This report studies the Influenza Vaccine market, covering market size for segment by type (Inactivated Vaccine, Live Attenuated Vaccine, etc.), by application (Pediatric, Adults, etc.), by sales channel (Direct Channel, Distribution Channel), by player (CSL, GSK, Sanofi, Mylan, AstraZeneca, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Influenza Vaccine from......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs